Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Breakthrough blood test could transform prostate cancer detection

NCT ID NCT06604130

Summary

This study is testing a new blood test that looks at RNA from tiny particles called exosomes to diagnose prostate cancer. Researchers want to see if this test can accurately identify prostate cancer and distinguish between aggressive and less serious forms. The study involves 1,600 men with elevated PSA levels who are scheduled for prostate biopsies.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Affiliated Hospital of Yan'an University,

    Yan’an, Shaanxi, 716000, China

  • General Hospital of Ningxia Medical University

    Yinchuan, Ningxia, 750000, China

  • Qinghai University Affiliated Hospital

    Xining, Qinghai, 810000, China

  • Shaanxi Provincial People's Hospital

    Xi'an, Shaanxi, 710000, China

  • The First Hospital of Lanzhou University

    Lanzhou, Gansu, 730000, China

  • The Second Affiliated Hospital of Shaanxi University of Chinese Medicine

    Xianyang, Shaanxi, 712000, China

  • Weinan Central Hospital

    Weinan, Shaanxi, 714000, China

  • Xijing 986 Hospital

    Xi'an, Shaanxi, 710000, China

  • Xijing Hospital

    Xi'an, Shaanxi, 710032, China

Conditions

Explore the condition pages connected to this study.